Recombinant vaccines in 2022: a perspective from the cell factory

Recombinant vaccines in 2022: a perspective from the cell factory

Abstract The last big outbreaks of Ebola fever in Africa, the thousands of avian influenza outbreaks across Europe, Asia, North America and Africa, the emergence of monkeypox virus in Europe and specially the COVID-19 pandemics have globally stressed the need for efficient, cost-effective vaccines a...

Full description

Bibliographic Details
Main Authors: Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, Eloi Parladé, Esther Vázquez, José Luis Corchero, Neus Ferrer-Miralles, Antonio Villaverde
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Microbial Cell Factories
Subjects:
Recombinant proteins
Vaccines
Antigens
Nanovaccines
Nanoparticles
VLPs
Online Access:https://doi.org/10.1186/s12934-022-01929-8

Internet

https://doi.org/10.1186/s12934-022-01929-8

Similar Items